Institute of Human Virology

Institute of Human Virology Institute of Human Virology (IHV) is the first Institute at University of Maryland School of Medicine
(355)

The Institute of Human Virology (IHV) is the first center in the United States - perhaps the world - to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV, the cause of AIDS. Formed in 1996 as a partnership bet

ween the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in the field of human virology. The Institute, with its various laboratory and patient care facilities, is uniquely housed in a 100,000-square-foot building located in the center of Baltimore and our nation’s HIV/AIDS pandemic. IHV creates an environment where multidisciplinary research, education and clinical programs work closely together to expedite the scientific understanding of HIV/AIDS pathogenesis and to develop therapeutic interventions to make AIDS and virally-caused cancers manageable, if not curable, diseases. A particular focus of IHV includes learning how to utilize the body's natural chemistry for its own therapeutic potential and pursuing biologically-based treatment approaches that are less toxic to the body and, often, less costly to the patient and public. IHV also pursues the development of effective therapeutic and preventative vaccines, science's greatest hope in putting an end to the AIDS pandemic. IHV's more than 300 employees include 73 faculty whose research efforts are focused in the area of chronic human viral infection and disease. At present, more than 75 percent of the Institute's clinical and research effort is targeted at HIV infection, but also includes the Hepatitis C virus, herpes viruses and cancer research.

Dr. Nicaise Ndembi, MSc, PhD, Associate Professor, Division of Epidemiology and Prevention at the Institute of Human Vir...
07/21/2025

Dr. Nicaise Ndembi, MSc, PhD, Associate Professor, Division of Epidemiology and Prevention at the Institute of Human Virology, has been named one of the 100 Most Notable Peace Icons in Africa at the 2025 Notable Africans Leadership and Business Summit in Kigali, Rwanda.

This recognition honors his impactful work in public health, peace-building, and development across the continent.

Congratulations, Dr. Ndembi! 👏🌍

We’re thrilled to share that Dr. Nicaise Ndembi, MSc, PhD, Associate Professor, Division of Epidemiology and Prevention at the Institute of Human Virology, has been named one of the 100 Most Notable Peace Icons in Africa at the 2025 Notable Africans Leadership and Business Summit in Kigali, Rwanda.

This recognition honors his impactful work in public health, peace-building, and development across the continent.

Congratulations, Dr. Ndembi! 👏🌍

05/29/2025

Members of IHV were present as The Jacques Initiative led this first, in-person Community of Practice meeting.

05/24/2025
Last week, a delegation from the Ministry of Health, Zambia, led by the Honorable Dr. Elijah Muchima, Minister of Health...
04/28/2025

Last week, a delegation from the Ministry of Health, Zambia, led by the Honorable Dr. Elijah Muchima, Minister of Health, visited Ciheb Global.

04/24/2025
In a media panel earlier this month, Dr. Sarah Kattakuzhy explained indirect costs fund and the potential impact on her ...
04/24/2025

In a media panel earlier this month, Dr. Sarah Kattakuzhy explained indirect costs fund and the potential impact on her research at the Institute of Human Virology and the Kahlert Institute for Addiction Medicine.

Dr. Shyam Kottilil is a source in The New York Times "How Measles Attacks an Unvaccinated Child" article.
04/07/2025

Dr. Shyam Kottilil is a source in The New York Times "How Measles Attacks an Unvaccinated Child" article.

With falling vaccination rates and outbreaks that have caused more than 580 U.S. cases and at least one death, health experts expect hundreds or even thousands more to be infected in the coming months.

Well, done, Dr. Alash’le Abimiku!
02/26/2025

Well, done, Dr. Alash’le Abimiku!

GVN member Dr. Alash’le Abimiku’s national study on HBV and HDV in Nigeria found an 8.1% HBV prevalence, with drug-resistant variants in 9.3% of cases and 7.34% HDV coinfection. These findings highlight the need for targeted HBV management strategies. Read more: https://tinyurl.com/2zw9zu8n

Institute of Human Virology

Dr. Shyam Kottilil was published with Dr. S. Sean Tu (West Virginia University College of Law) and Dr. T. Joseph Matting...
02/24/2025

Dr. Shyam Kottilil was published with Dr. S. Sean Tu (West Virginia University College of Law) and Dr. T. Joseph Mattingly II (The University of Utah College of Pharmacy) in the The New England Journal of Medicine highlighting how available drugs could potentially advance U.S. Hepatitis C elimination efforts.

Read here: https://rb.gy/de1g5z

February is Heart Health Month!
02/14/2025

February is Heart Health Month!

Address

725 W Lombard Street
Baltimore, MD
21201

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Institute of Human Virology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category

Our Story

The Institute of Human Virology (IHV) is the first center in the United States - perhaps the world - to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV, the cause of AIDS.

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in the field of human virology. IHV was co-founded by Robert Gallo, MD, director of the of the IHV, William Blattner, MD, retired since 2016 and formerly associate director of the IHV and director of IHV’s Division of Epidemiology and Prevention and Robert Redfield, MD, resigned in March 2018 to become director of the U.S. Centers for Disease Control and Prevention (CDC) and formerly associate director of the IHV and director of IHV’s Division of Clinical Care and Research. In addition to the two Divisions mentioned, IHV is also comprised of a Basic Science Division, Vaccine Research Division, Immunotherapy Division, Center for International Health, Education and Biosecurity (CIHEB) and four Scientific Core Facilities.

The Institute, with its various laboratory and patient care facilities, is uniquely housed in a 250,000-square-foot building located in the center of Baltimore and our nation’s HIV/AIDS pandemic. IHV creates an environment where multidisciplinary research, education, and clinical programs work closely together to expedite the scientific understanding of HIV/AIDS pathogenesis and to develop therapeutic interventions to make AIDS and virally-caused cancers manageable, if not curable, diseases.

A particular focus of IHV includes learning how to utilize the body's natural chemistry for its own therapeutic potential and pursuing biologically-based treatment approaches that are less toxic to the body and, often, less costly to the patient and public. IHV also pursues the development of effective therapeutic and preventative vaccines, science's greatest hope in putting an end to the AIDS pandemic.L